前列腺癌
谷氨酸羧肽酶Ⅱ
医学
分子成像
前列腺
正电子发射断层摄影术
医学物理学
癌症
临床实习
放射科
核医学
内科学
体内
生物
生物技术
家庭医学
作者
Matthias Eiber,Ken Herrmann,Jérémie Calais,Boris Hadaschik,Frederik L. Giesel,Markus Hartenbach,Thomas A. Hope,Robert E. Reiter,Tobias Maurer,Wolfgang Weber,Wolfgang P. Fendler
标识
DOI:10.2967/jnumed.117.198119
摘要
Prostate-specific membrane antigen (PSMA)–ligand PET imaging provides unprecedented accuracy for whole-body staging of prostate cancer. As PSMA-ligand PET/CT is increasingly adopted in clinical trials and routine practice worldwide, a unified language for image reporting is urgently needed. We propose a molecular imaging TNM system (miTNM, version 1.0) as a standardized reporting framework for PSMA-ligand PET/CT or PET/MRI. miTNM is designed to organize findings in comprehensible categories to promote the exchange of information among physicians and institutions. Additionally, flowcharts integrating findings of PSMA-ligand PET and morphologic imaging have been designed to guide image interpretation. Specific applications, such as assessment of prognosis or impact on management, should be evaluated in future trials. miTNM is a living framework that evolves with clinical experience and scientific data.
科研通智能强力驱动
Strongly Powered by AbleSci AI